Company
Perth, WA
Every investor coverage indicates participated in a round Artrya raised.
Companies Artrya acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| John Barrington AM | Managing Director | Startup News (WA) |
| Mathew Regan | CEO | @AuManufacturing |
Stories naming Artrya. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup: Artrya's $5m placement, Traffic Technologies' $2.8m entitlement offer, Rhythm's R&D tax refund, Hydramech's grant, Orthocell hires, a Standards Australia board election, and Aristocrat's agreed Plarium sale.
Startup West podcast episode with Artrya co-founder John Barrington on the ASX-listed healthtech firm, which raised $40 million when it listed in November 2021 at a $105 million valuation.
US-based leadless pacemaker maker EBR Systems has listed on the ASX, spurning US SPAC offers thanks to its local investor base; Blackbird's earlier investment in Vexev is also noted.
Also Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio
Techboard's annual report finds Australian early-stage startup funding passed $10 billion in FY21, up 64%, while WA companies attracted just $50 million, with ASX raises dominating and female founders' funding share falling.
Weekly roundup covering CBA's strategic stakes in Little Birdie and Amber, several Australian funding rounds, Zip's BNPL acquisitions, Tritium's planned NASDAQ listing, Amazon's MGM purchase and other global tech news.
Also Startup Daily·Startup Daily·Startup Daily·Startup Daily·SmartCompany·Startup Daily·SmartCompany·Startup Daily·Startup Daily·Startup Daily·SmartCompany·Women's Agenda